Related Experiment Video
Updated: May 6, 2026
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.8K
Prioritizing multipurpose prevention technology development and investments using a target product profile
Joe Romano1, Judy Manning, Anke Hemmerling
1NWJ Group, LLC, USA.
Antiviral Research
|November 6, 2013
Summary
Multipurpose prevention technologies (MPTs) offer a cost-effective way to meet women's sexual health needs. Prioritizing MPT products and addressing technology gaps is crucial for global public health impact.
Area of Science:
- Sexual and Reproductive Health
- Infectious Disease Prevention
- Biomedical Product Development
Background:
- Multipurpose prevention technologies (MPTs) are vital for addressing unmet sexual and reproductive health needs globally.
- Developing MPTs for combined prevention of pregnancy and sexually transmitted infections (STIs), including HIV, is complex and resource-intensive.
- A structured approach is needed to prioritize MPT products and guide investment for maximum public health impact.
Purpose of the Study:
- To establish an objective process for identifying MPT products with the highest public health impact potential.
- To define specific MPT product priorities and identify technology gaps hindering optimal product development.
- To guide product development strategies and coordinate investments from supporting agencies.
Main Methods:
- The Scientific Agenda Working Group of the Initiative for Multipurpose Prevention Technologies conducted an MPT pipeline evaluation exercise.
- A formal and objective process was employed to assess MPT products and identify development priorities.
- The exercise aimed to define MPT product priorities and pinpoint technology gaps.
Main Results:
- A set of priority MPT product recommendations was identified through the evaluation.
- Several priority MPT technology gaps requiring further research and development were highlighted.
- Specific priorities for the MPT development process were also determined.
Conclusions:
- The MPT pipeline evaluation provides a framework for prioritizing investments and guiding product development.
- Addressing identified MPT technology gaps is essential for advancing the development of optimal MPT products.
- Coordinated efforts are necessary to accelerate the development and delivery of impactful MPTs for women worldwide.
More Related Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
1.1K
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
14.4K
Related Concept Videos
01:30Preventive Healthcare Services
2.5K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.5K
01:26Levels of Health Promotion and Illness Prevention
12.9K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.9K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
561
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
561
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K